Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria - PubMed (original) (raw)
. 2001 Oct 1;61(19):7339-48.
Affiliations
- PMID: 11585775
Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria
X D Zhang et al. Cancer Res. 2001.
Abstract
In previous studies we have shown that the sensitivity of melanoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis was determined largely by the level of expression of death receptor TRAIL receptor 2 on the cells. However, approximately one-third of melanoma cell lines were resistant to TRAIL, despite expression of high levels of TRAIL receptor 2. The present studies show that these cell lines had similar levels of TRAIL-induced activated caspase-3 as the TRAIL-sensitive lines, but the activated caspase-3 did not degrade substrates downstream of caspase-3 [inhibitor of caspase-activated DNase and poly(ADP-ribose) polymerase]. This appeared to be due to inhibition of caspase-3 by X-linked inhibitor of apoptosis (XIAP) because XIAP was bound to activated caspase-3, and transfection of XIAP into TRAIL-sensitive cell lines resulted in similar inhibition of TRAIL-induced apoptosis. Conversely, reduction of XIAP levels by overexpression of Smac/DIABLO in the TRAIL-resistant melanoma cells was associated with the appearance of catalytic activity by caspase-3 and increased TRAIL-induced apoptosis. TRAIL was shown to cause release of Smac/DIABLO from mitochondria, but this release was greater in TRAIL-sensitive cell lines than in TRAIL-resistant cell lines and was associated with down-regulation of XIAP levels. Furthermore, inhibition of Smac/DIABLO release by overexpression of Bcl-2 inhibited down-regulation of XIAP levels. These results suggest that Smac/DIABLO release from mitochondria and its binding to XIAP are an alternative pathway by which TRAIL induces apoptosis of melanoma, and this pathway is dependent on the release of activated caspase-3 from inhibition by XIAP and possibly other inhibitor of apoptosis family members.
Similar articles
- Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines.
Izeradjene K, Douglas L, Tillman DM, Delaney AB, Houghton JA. Izeradjene K, et al. Cancer Res. 2005 Aug 15;65(16):7436-45. doi: 10.1158/0008-5472.CAN-04-2628. Cancer Res. 2005. PMID: 16103097 - Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K, Douglas L, Delaney A, Houghton JA. Izeradjene K, et al. Clin Cancer Res. 2004 Oct 1;10(19):6650-60. doi: 10.1158/1078-0432.CCR-04-0576. Clin Cancer Res. 2004. PMID: 15475455 - Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors.
Aggarwal BB, Bhardwaj U, Takada Y. Aggarwal BB, et al. Vitam Horm. 2004;67:453-83. doi: 10.1016/S0083-6729(04)67023-3. Vitam Horm. 2004. PMID: 15110190 Review. - TRAIL induces apoptosis and activation of NFkappaB.
Jeremias I, Debatin KM. Jeremias I, et al. Eur Cytokine Netw. 1998 Dec;9(4):687-8. Eur Cytokine Netw. 1998. PMID: 9889416 Review.
Cited by
- Nano-TRAIL: a promising path to cancer therapy.
Gampa SC, Garimella SV, Pandrangi S. Gampa SC, et al. Cancer Drug Resist. 2023 Feb 1;6(1):78-102. doi: 10.20517/cdr.2022.82. eCollection 2023. Cancer Drug Resist. 2023. PMID: 37065863 Free PMC article. Review. - Enhancing the Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Signaling and Arginine Deprivation in Melanoma.
Wu C, You M, Nguyen D, Wangpaichitr M, Li YY, Feun LG, Kuo MT, Savaraj N. Wu C, et al. Int J Mol Sci. 2021 Jul 16;22(14):7628. doi: 10.3390/ijms22147628. Int J Mol Sci. 2021. PMID: 34299249 Free PMC article. Review. - Cytotoxic Efficacy and Resistance Mechanism of a TRAIL and VEGFA-Peptide Fusion Protein in Colorectal Cancer Models.
Kopczynski M, Statkiewicz M, Cybulska M, Kuklinska U, Unrug-Bielawska K, Sandowska-Markiewicz Z, Grochowska A, Gajewska M, Kulecka M, Ostrowski J, Mikula M. Kopczynski M, et al. Int J Mol Sci. 2021 Mar 19;22(6):3160. doi: 10.3390/ijms22063160. Int J Mol Sci. 2021. PMID: 33808900 Free PMC article. - Countering TRAIL Resistance in Melanoma.
Eberle J. Eberle J. Cancers (Basel). 2019 May 11;11(5):656. doi: 10.3390/cancers11050656. Cancers (Basel). 2019. PMID: 31083589 Free PMC article. Review. - TRAILblazing Strategies for Cancer Treatment.
Kretz AL, Trauzold A, Hillenbrand A, Knippschild U, Henne-Bruns D, von Karstedt S, Lemke J. Kretz AL, et al. Cancers (Basel). 2019 Mar 30;11(4):456. doi: 10.3390/cancers11040456. Cancers (Basel). 2019. PMID: 30935038 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials